Edoxaban
Spécifications
480449-70-5Numéro CAS
859-181-7Numéro CE
N'-(5-chloro-2-pyridinyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamideNom IUPAC
C24H30ClN7O4SFormule chimique
548.1 g/molMasse molaire
EDOXABAN; 480449-70-5; DU-176; NDU3J18APO; CHEBI:85973; DTXSID50197398; N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-amido}cyclohexyl]ethanediamide; edoxabanum; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4-((dimethylamino)carbonyl)-2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-; N'-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-((5-methyl6,7-dihydro-4H-(1,3)thiazolo(5,4-c)pyridine-2-carbonyl)amino)cyclohexyl)oxamide; N'-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4H,5H,6H,7H-(1,3)thiazolo(5,4-c)pyridine-2-amido)cyclohexyl)ethanediamide; N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide; N-(5-chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxamide; RefChem:58094; edoxaban tosilate hydrochloride; B01AF03; DTXCID60119889; 912273-65-5; MFCD13195544; DU-176b; N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide; CHEMBL1269025; N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide; C24H30ClN7O4S; Edoxaban [USAN]; Edoxaban [USAN:INN]; UNII-NDU3J18APO; N1-(5-Chloropyridin-2-yl)-N2-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxalamide; 480449-70-5 (free base); Edoxaban (Standard); Edoxaban (USAN/INN); EDOXABAN [INN]; EDOXABAN [MI]; EDOXABAN [MART.]; EDOXABAN [WHO-DD]; SCHEMBL330046; GTPL7575; orb1305585; orb3141300; HSDB 8406; HGVDHZBSSITLCT-JLJPHGGASA-N; GLXC-90139; EX-A5582; BDBM50328731; EBC-27305; HY-10264R; MSK159568; s4429; T2368L; AKOS005146069; CS-1331; DB09075; FC71602; NCGC00378907-01; NCGC00378907-02; NCGC00378907-03; AC-35419; AS-35107; HY-10264; N1-(5-Chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide; SY097689; 5436B; D09710; EN300-20605508; F799088; Q21011234; Z2301684749; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4- ((dimethylamino)carbonyl)- 2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-; N'-(5-chloro-2-pyridinyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N'-(5-chloro-2-pyridyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N'-(5-chloropyridin-2-yl)-N-[(1s,2r,4s)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4h-[1,3] thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N(1)-(5-chloropyridin-2-yl)-N(2)-{(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl}ethanediamide; N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carb onyl]amino]cyclohexyl]ethanediamide; N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide; N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl]ethanediamide; N~1~-(5-Chloropyridin-2-yl)-N~2~-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]ethanediamide; N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5, 6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl) ethanediamide; N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide; N1-(5-Chloropyridin-2-yl)-N2-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl]ethanediamideSynonymes
Produits contenant Edoxaban
EDOXABAN NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEDOXABAN NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEDOXABAN NORMON 15 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGFientalf 15 mgFientalf 30 mgFientalf 60 mgEdoxbin 60Edoxbin 30Lasaban 15Lasaban 30Lasaban 60Edoxaban Tosylate - IOL Chemicals and Pharmaceuticals
Page 1 sur 5
Entreprises vendant Edoxaban
CT
Công ty TNHH DRP InterViet NamAP
Aurobindo Pharma LimitedIndiaDR
Dr. Reddy's LaboratoriesIndiaML
MSN LaboratoriesIndiaZS
Zhejiang Supor Pharmaceuticals Co., LTDChinaPage 1 sur 4